Movement Disorders

The NeurologyLive movement disorders clinical focus page is a source for all the latest news regarding the clinical care of patients with Parkinson disease, essential tremor, Huntington disease, dystonia, ataxia, and more. This page features podcasts, videos, and news about FDA actions, study and clinical trial findings, clinical guideline updates, and interviews with experts in the clinical care of movement disorders.

Episode 62: Advanced Therapeutics in Parkinson and Movement Disorders

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Yasar Torres-Yaghi, MD.

Parkinson Disease: Managing Off-Episodes

Two experts discuss what it means to have an off-episode as a patient with Parkinson’s disease, as well as how to live with them and what can be done to alleviate adverse events.

NeuroVoices: Rodolfo Savica, MD, PhD, on Parkinson Disease Awareness Month

NeuroVoices: Gennero Pagano, MD, MSc, PhD, on Prasinezumab for Parkinson Disease

The expert medical director at Roche provided context on recently published data, which showed prasinezumab’s positive impact in delaying motor progression in patients with Parkinson disease.

The Need to Find Valuable Parkinson Disease Biomarkers: Mark Lew, MD

May 23, 2022

Video

The director of the Division of Movement Disorders at the USC Keck School of Medicine discussed the early reactions behind reflex tears as a potential biomarker for Parkinson disease. [WATCH TIME: 2 minutes]

Applying Connectomics to Neurosurgery: Michael Sughrue, MD

May 23, 2022

Video

The founder and chief medical officer of Omniscient Neurotechnology provided insight on the successes using connectomics, including the FDA approval of Quicktome, a digital brain mapping platform. [WATCH TIME: 4 minutes]

This Week on NeurologyLive® — May 23, 2022

May 23, 2022

Article

Here's what is coming soon to NeurologyLive®.

NeurologyLive® Brain Games: May 22, 2022

May 22, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuropathic disorders.

New Drug Application Submitted for Continuous Subcutaneous Carbidopa/Levodopa Formulation

May 21, 2022

Article

If approved, ABBV-951 would become the first subcutaneous delivery of levodopa and carbidopa, the gold standard for symptom management in Parkinson disease.

NeurologyLive® Friday 5 — May 20, 2022

May 20, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 20, 2022.

Understanding Connectomics and the Power of Artificial Intelligence to Help Improve Brian Mapping: Michael Sughrue, MD

May 20, 2022

Video

The founder and chief medical officer of Omniscient Neurotechnology discussed the idea behind connectomics and how AI revolutionizes large-scale brain data. [WATCH TIME: 4 minutes]

ON Time vs OFF Episodes in PD

May 18, 2022

Video

Robert A. Hauser, MD, MBA, and Rajesh Pahwa, MD, define the difference between ON time and OFF episodes for patients with Parkinson disease.

Role of Levodopa in Managing Parkinson Disease

May 18, 2022

Video

Rajesh Pahwa, MD, reviews the use of levodopa for the management of Parkinson disease symptoms.

NeuroVoices: Mark Lew, MD, on the Validation of Tears as a Biomarker for Parkinson Disease

May 18, 2022

Article

The director of the Division of Movement Disorders at the USC Keck School of Medicine provided insight on the next steps to justify whether reflex tears are a reliable biomarker for Parkinson disease.

Latest News

The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley

American Stroke Association Publishes Updated Guidance for Intracerebral Hemorrhage

FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine

Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD

View More News